Human bodies do a lot of weird stuff. But goosebumps may be one of our strangest bodily functions. Goosebumps are humanitys near-universal reaction to the cold.
Human bodies do a lot of weird stuff. But goosebumps may be one of our strangest bodily functions. Goosebumps are humanitys near-universal reaction to the cold.
We all know what goosebumps are, but why have we evolved to hang on to this seemingly pointless physical reaction to the cold? New research suggests an answer: regulating stem cells that control hair follicles and hair growth. In a detailed analysis of mice, scientists found that the specific muscles that contract when goosebumps appear are connected to the sympathetic nervous system.
Harvard scientists find that the same cell types that cause goosebumps are responsible for controlling hair growth.
Its Friday! Since most of our news consumption consists of bad news, especially during this time with a pandemic, rioting, protests, murder hornets, alcoholic killer monkeys, meth gators, and squirrels carrying the Bubonic Plague.
Today, Canadian Blood Servicesand Canadas COVID-19 Immunity Task Force (CITF)are releasing initial results of the first 10,000 blood donor samples assessed for SARS-CoV-2 antibodies. This analysis reveals that over the period May 9 through June 8, 2020, fewer than 1 per cent of the 10,000 samples from blood donors tested positive for antibodies to the novel coronavirus
On July 24, the Food and Drug Administration (FDA) granted accelerated approval of a new CAR-T therapy, Tecartus (brexucabtagene autoleucel), for adults with mantle cell lymphoma who have not responded to or who have relapsed after other kinds of treatment. Tecartus (formerly known as KTE-X19), manufactured by Kite, a Gilead Company, is a living drug that reprograms a patients own T cells to fight cancer. About two thirds of participants treated in the ZUMA-2 study experienced complete remission, which in a majority of cases lasted at least a year.
Science and research have always relied on using animals to understand various human diseases. The primarily reasons have been the genetic similarity between animals and humans (mice share 98% of DNA with us), and that we have developed tools to edit genes in various animals.
Abstract More than 1050 clinical trials are registered at FDA.gov that explore multipotent mesenchymal stromal cells (MSCs) for nearly every clinical application imaginable, including neurodegenerative and cardiac disorders, perianal fistulas, graft-versus-host disease, COVID-19, and cancer.
Ooops... Error 404 Sorry, but the page you are looking for doesn't exist
R3 International is now including exosomes with its stem cell therapy program in Mexico for autism. They have been shown to be an effective, safe option for autism patients. SCOTTSDALE, Ariz., July 23, 2020 /PRNewswire-PRWeb/ --R3 International is now including exosomes with its stem cell therapy program in Mexico for autism
Recent Comments